Search Results

HYBRIDOMAS: Why Combine Lymphocytes and Cancer Cells?

Subjects: MEDICAL sciences; CANCER cells; HYBRIDOMAS

• Source: OYLA Magazine. Apr2024, Issue 41, p14-17. 4p. 3 Color Photographs, 3 Diagrams.

Record details

FDA Approves Jemperli as Frontline Treatment for Advanced Endometrial Cancer.

Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG approval; DISEASE progressionUNITED StatesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 8/1/2023, p1-2. 2p.

Record details

Monoclonal Antibodies: From Skepticism to Success.

• Authors : TRAN, LAURA

Subjects: MONOCLONAL antibodies; B cells; IMMUNOGLOBULIN producing cells

• Source: Scientist. Spring2024, Vol. 38 Issue 1, p61-64. 4p.

Record details

FDA Advisory Committee Supports Donanemab in Alzheimer's Disease.

• Authors : Myshko, Denise

Subjects: *GROUP decision making; *COMMITTEES; THERAPEUTIC use of monoclonal antibodiesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 6/11/2024, p1-1. 1p.

Record details

FDA Sets Date of Advisory Committee Meeting for Donanemab in Alzheimer's Disease.

Subjects: *MEETINGS; ALZHEIMER'S disease prevention; THERAPEUTIC use of monoclonal antibodiesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 5/7/2024, p2-2. 1p.

Record details

Biogen to Stop Selling Alzheimer's Drug Aduhelm.

• Authors : Myshko, Denise

Subjects: *PRODUCT recall; *SALES personnel; *PHARMACEUTICAL industryUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/1/2024, p1-1. 1p.

Record details

FDA Sets Date for First-in-Class Lung Cancer Therapy.

Subjects: *QUALITY assurance; THERAPEUTIC use of monoclonal antibodies; LUNG cancerUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/20/2024, p1-1. 1p.

Record details

Is complement therapy the path forward for geographic atrophy? The 2 most developed therapies for GA are C3 and C5 inhibitors.

• Authors : Kovach, Jaclyn L.¹

Subjects: *THERAPEUTIC use of monoclonal antibodies; *DISEASE progression; *RETINAL degeneration

• Source: Ophthalmology Times. Jul2023, Vol. 48 Issue 7, p18-22. 3p.

Record details

Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.

• Authors : Khurana, Sharad; Heckman, Michael G.; Craig, Fiona E.

Subjects: LYMPHOBLASTIC leukemia diagnosis; THERAPEUTIC use of antineoplastic agents; THERAPEUTIC use of monoclonal antibodies

• Source: Archives of Pathology & Laboratory Medicine. Apr2024, Vol. 148 Issue 4, p471-475. 5p.

Record details

Relapsing polychondritis associated with pustular psoriasis successfully treated with secukinumab: a case-based review.

• Authors : Song, Qicheng; Wang, Zhankui

Subjects: THERAPEUTIC use of monoclonal antibodies; PSORIASIS; ERYTHEMACHINA

• Source: Egyptian Rheumatology & Rehabilitation; 7/1/2024, Vol. 51 Issue 1, p1-8, 8p

Record details